Home
Conditions
beta-Thalassemia

Clinical trial condition

beta-Thalassemia

Explore clinical trials studying beta-Thalassemia. Study availability and eligibility vary by location and protocol.

184 public trials 29 recruiting studies

Refine in advanced search Browse all conditions

beta-Thalassemia trial results

Recruiting

A Multiple Ascending Dose Study of 9MW3011 in Patients With Non-transfusion-dependent β-thalassemia

NCT06772766

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations: The first Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China

Hainan General Hospital Haikou, Hainan, China

View Trial Details

Recruiting

Clinical Study of Super Transplantation in the Treatment of Severe β-thalassemia

NCT06734520

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +9 more
Locations: Guangzhou Women and Children's Medical Center Affiliated to Guangzhou Medical University Guangzhou, Guangdong, China

Guangzhou Women and Children's Medical Center Affiliated to Guangzhou Medical University Guangzhou, Guangdong, China

View Trial Details

Recruiting

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

NCT06539169

Conditions: Alpha-Thalassemia, Alzheimer Disease, Amyloidosis, +104 more
Locations: xCures Los Altos, California, United States

View Trial Details

Recruiting

A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or β-thalassemia

NCT06073860

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +11 more
Locations: Local Institution - 0001 Seoul, South Korea

Novotech Laboratory Korea Co., Ltd. Seoul, South Korea

View Trial Details

Recruiting

Adherence of Beta Thalssemia Patients to Oral Chelation Therapy

NCT06568926

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations: Sohag university Hospital Sohag, Egypt

View Trial Details

Recruiting

Study of the Role of Genetic Modifiers in Hemoglobinopathies

NCT05799118

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +12 more
Locations: Boston Children's Hospital Boston, Massachusetts, United States

Lucrecia Paím Maternity Luanda, Angola

University of Buenos Aires Buenos Aires, Argentina

University Hospitals Leuven Leuven, Belgium

View all 26 locations

View Trial Details

Recruiting

Long-term Follow-up Study of BHC001 for TDT

NCT06314529

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations: The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army Nanning, Guangxi, China

Xiangya Hospital of Central South University Changsha, Hunan, China

View Trial Details

Recruiting

RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)

NCT06213402

Conditions: Anemia, Anemia Due to Membrane Defect, Anemia, Hemolytic, +29 more
Locations: Vall d'hebron Research Institute - Vall d'Hebron Research Institute - University Hospital Vall d'Hebrón (VHIR/HUVH) Barcelona, Catalonia, Spain

View Trial Details

Recruiting

A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia [TDT]

NCT05762510

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations: The affiliated hospital of guangxi medical university Nanning, Guangxi, China

View Trial Details

Enrolling by Invitation

CS-101 in Patients With β-thalassemia

NCT06328764

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations: The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China

View Trial Details

beta-Thalassemia

beta-Thalassemia trial results

Related conditions